USPTO serial 90700877
STRATEOS SMARTLAB STUDIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- PATEL, SAMIR RAMESH
- Law office
- TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with STRATEOS SMARTLAB STUDIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Menlo Park, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stacey J. Watson, Esq.
STACEY J. WATSON, ESQ. MARKERY LAW LLCP.O. BOX 84150GAITHERSBURG, MD 20883-4150UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Software as a service ("SAAS") featuring access to remote and on-demand automated cloud labs accessible from a web browser that enable users around the world to easily access and control drug discovery, cell and gene therapy and synthetic biology workflows; Workflows for designing laboratory experiments, for running laboratory experiments, generating data, for reviewing and analyzing laboratory and environmental data, and experiment results; Provide support to the pharmaceutical, biotechnology, healthcare, synthetic biology, agscience and medical device industries in the form of research services, biopharmaceutical development, biologic assay development, commercialization, preclinical research, clinical research, and pharmacovigilance; software as a service ("SAAS") featuring software for running computer simulations of laboratory experiments, for running computer simulations of biological and chemical phenomena and systems, for optimizing laboratory experiment parameters with computational methods, and for comparison of computer simulations against empirically observed laboratory experiment results; software as a service ("SAAS") featuring software for research and development of chemicals, pharmaceuticals, biologics, and vaccines, and cell and gene therapies; software as a service ("SAAS") for providing regulatory compliance documentation following experiments, for performing regulatory agencies audits following experiments, and for performing internal audits following experiments; conducting laboratory experiments on behalf of others; scientific testing of chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; toxicological testing services for pharmaceuticals, chemicals, biologics, vaccines, and cell and gene therapies; biopharmaceutical and synthetic biology research design and scientific testing services; custom assay development for chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; technological consultancy in the field of information technology; technological consultancy in the field of life sciences, drug discovery, synthetic biology software engineering, hardware engineering and laboratory automation | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 1, 2022 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 1, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 15, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 10, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 13, 2021 | NWAP | NEW APPLICATION ENTERED | — |